Regnum (Regnum) EBITDA Margin %

: 0.00% (As of Mar. 2023)

View and export this data going back to 2019. Start your Free Trial

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Regnum's EBITDA for the three months ended in Mar. 2023 was $-0.18 Mil. Regnum's Revenue for the three months ended in Mar. 2023 was $0.00 Mil. Therefore, Regnum's EBITDA margin for the quarter that ended in Mar. 2023 was 0.00%.

Regnum EBITDA Margin % Historical Data

The historical data trend for Regnum's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regnum Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBITDA Margin %

19.05

-583.33

-1,255.56

Regnum Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EBITDA Margin %																-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Regnum's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regnum EBITDA Margin % Distribution

For the Biotechnology industry and Healthcare sector, Regnum's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Regnum's EBITDA Margin % falls into.

Regnum EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Regnum's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-0.736	/	0
	=	%

Regnum's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-0.179	/	0
	=	%

Regnum (OTCPK:RGMP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Regnum EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Regnum's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regnum (Regnum) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

600 Third Avenue, 19th Floor, New York, NY, USA, 10016

Website

https://www.regnumcorp.com

Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.

Regnum (Regnum) Headlines

No Headlines